Mild Cognitive Impairment

Mild Cognitive Impairment is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

5-Minute Clinical Consult (5MCC) app and website powered by Unbound Medicine helps you diagnose and manage 900+ medical conditions. Exclusive bonus features include Diagnosaurus DDx, 200 pediatrics topics, and medical news feeds. Explore these free sample topics:

5-Minute Clinical Consult

-- The first section of this topic is shown below --



  • Mild cognitive impairment (MCI) is defined as significant cognitive impairment in the absence of dementia, as measured by standard memory tests:
    • Concern regarding change in cognition
    • Preservation of independence in functional activities (ADLs)
    • Impairment in ≥1 cognitive domains (attention, executive dysfunction, memory, visuospatial, language)
    • Other terms used in the literature relating to MCI: isolated memory impairment; cognitive impairment not dementia (CIND); predementia; mild cognitive disorder; age-associated memory impairment; age-related cognitive decline; benign senescent forgetfulness. Some of these conditions do not progress to dementia (i.e., benign senescent forgetfulness, age-associated memory impairment, age-related cognitive decline). DSM-5 mentions “mild neurocognitive disorder” (mNCD), which may be a precursor to Alzheimer disease and has many of the same features as MCI.
  • Older adults with MCI are 3 times more likely to progress to dementia in 2 to 5 years than age matched cohorts (1)[A].


  • Predominant sex: male > female
  • Predominant age:
    • Higher in older persons and in those with less education
    • 12 to 15/1,000 person-years in those age ≥65 years
    • 54/1,000 person-years in those age ≥75 years

  • MCI is more prevalent than dementia in the United States.
  • 12–18% for those age ≥60 years (2)

Etiology and Pathophysiology

  • Subtypes of MCI:
    • Single-domain amnestic
    • Multiple-domain amnestic
    • Nonamnestic single-domain
    • Nonamnestic multiple-domain
  • The amnestic subtype is higher risk for progression to Alzheimer disease.
  • Vascular, degenerative, traumatic, metabolic, psychiatric, or a combination

Apolipoprotein (APO) E4 genotype: Various pathways exist leading to amyloid accumulation and deposition thought to be associated with dementia.

Risk Factors

  • Age
  • Diabetes
  • Hypertension
  • Hyperlipidemia
  • Cerebrovascular disease
  • Smoking
  • Sleep apnea
  • APO E4 genotype

Commonly Associated Conditions

See “Risk Factors.”

-- To view the remaining sections of this topic, please or purchase a subscription --